Tangeretin synergizes with imatinib in inhibiting growth of bcr-abl positive K562 Erythroleukemia cells in an Erk-dependent way
- Author
- Sofie Lust (UGent) , Barbara Vanhoecke (UGent) , marc bracke and Fritz Offner (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-308133
- MLA
- Lust, Sofie, et al. “Tangeretin Synergizes with Imatinib in Inhibiting Growth of Bcr-Abl Positive K562 Erythroleukemia Cells in an Erk-Dependent Way.” BLOOD, vol. 104, no. 11, AMER SOC HEMATOLOGY, 2004, p. 576.
- APA
- Lust, S., Vanhoecke, B., bracke, marc, & Offner, F. (2004). Tangeretin synergizes with imatinib in inhibiting growth of bcr-abl positive K562 Erythroleukemia cells in an Erk-dependent way. BLOOD, 104(11), 576. AMER SOC HEMATOLOGY.
- Chicago author-date
- Lust, Sofie, Barbara Vanhoecke, marc bracke, and Fritz Offner. 2004. “Tangeretin Synergizes with Imatinib in Inhibiting Growth of Bcr-Abl Positive K562 Erythroleukemia Cells in an Erk-Dependent Way.” In BLOOD, 104:576. AMER SOC HEMATOLOGY.
- Chicago author-date (all authors)
- Lust, Sofie, Barbara Vanhoecke, marc bracke, and Fritz Offner. 2004. “Tangeretin Synergizes with Imatinib in Inhibiting Growth of Bcr-Abl Positive K562 Erythroleukemia Cells in an Erk-Dependent Way.” In BLOOD, 104:576. AMER SOC HEMATOLOGY.
- Vancouver
- 1.Lust S, Vanhoecke B, bracke marc, Offner F. Tangeretin synergizes with imatinib in inhibiting growth of bcr-abl positive K562 Erythroleukemia cells in an Erk-dependent way. In: BLOOD. AMER SOC HEMATOLOGY; 2004. p. 576.
- IEEE
- [1]S. Lust, B. Vanhoecke, marc bracke, and F. Offner, “Tangeretin synergizes with imatinib in inhibiting growth of bcr-abl positive K562 Erythroleukemia cells in an Erk-dependent way,” in BLOOD, 2004, vol. 104, no. 11, p. 576.
@inproceedings{308133, author = {{Lust, Sofie and Vanhoecke, Barbara and bracke, marc and Offner, Fritz}}, booktitle = {{BLOOD}}, issn = {{0006-4971}}, language = {{eng}}, number = {{11}}, pages = {{576A-576A}}, publisher = {{AMER SOC HEMATOLOGY}}, title = {{Tangeretin synergizes with imatinib in inhibiting growth of bcr-abl positive K562 Erythroleukemia cells in an Erk-dependent way}}, volume = {{104}}, year = {{2004}}, }